Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Maria Chiara Iachini"'
Autor:
Federica Pierucci, Fabio Francini, Elena Lenci, Maria Chiara Iachini, Catia Vicenti, Elisabetta Meacci, Rachele Garella, Alessia Frati, Maria Caterina Baccari, Roberta Squecco, Maria Martinesi, Eglantina Idrizaj
Publikováno v:
Molecular and Cellular Biochemistry
The widespread environmental pollutant 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153) is a non-dioxin-like toxicant. It is a potential carcinogen compound able to induce gap junction (GJ) intercellular communication impairment, probably the first n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e07c5592fb306dc596a58af893acda79
https://doi.org/10.1007/s11010-021-04135-z
https://doi.org/10.1007/s11010-021-04135-z
Autor:
Robin L. Owen, Joanne E. Nettleship, Thomas Simon, Angeliki Ditsiou, Shivani Soni, Laurence H. Pearl, Chrisostomos Prodromou, Athanasios Papakyriakou, John Spencer, Maria Chiara Iachini, Lihong Zhou, Leanne Milton-Harris, Teresa Gagliano, Jae Ho Lo, Goar Smbatyan, Heinz-Josef Lenz, Sahir Khurshid, Storm Hassell-Hart, Philip Carter, Raymond J. Owens, Naomi E. Chayen, Georgios Giamas, Viviana Vella, Apostolos Klinakis, Panagiota Ntavelou, S. Mark Roe, Justin Stebbing, Chiara Cilibrasi, Nikiana Simigdala
Publikováno v:
Science Advances
The structure of oncogenic LMTK3 determines its role and functions allowing drug inhibition as a new therapeutic strategy.
Elucidating signaling driven by lemur tyrosine kinase 3 (LMTK3) could help drug development. Here, we solve the crystal st
Elucidating signaling driven by lemur tyrosine kinase 3 (LMTK3) could help drug development. Here, we solve the crystal st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218bf1104e6c0496d79e2bad312b2532
http://hdl.handle.net/10044/1/84171
http://hdl.handle.net/10044/1/84171
Autor:
Elisabetta Meacci, Maria Chiara Iachini, Fabio Penna, Federica Pierucci, Francesca Matteini, Paola Costelli, Chiara Battistini, Ambra Vestri, Alessia Frati
Skeletal muscle (SkM) atrophy is caused by several and heterogeneous conditions, such as cancer, neuromuscular disorders and aging. In most types of SkM atrophy overall rates of protein synthesis are suppressed, protein degradation is consistently el
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad6ee99ab40b3975e3771aa24133313e
http://hdl.handle.net/2318/1684959
http://hdl.handle.net/2318/1684959